Page last updated: 2024-09-05

mk 0852 and lamifiban

mk 0852 has been researched along with lamifiban in 1 studies

Compound Research Comparison

Studies (mk 0852)	Trials (mk 0852)	Recent Studies (post-2010) (mk 0852)	Studies (lamifiban)	Trials (lamifiban)	Recent Studies (post-2010) (lamifiban)
17	2	0	84	12	2

Protein Interaction Comparison

Protein	Taxonomy	mk 0852 (IC50)	lamifiban (IC50)
Integrin beta-3	Homo sapiens (human)		0.0157
Integrin alpha-IIb	Homo sapiens (human)		0.0157

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Rossi, G	1

Other Studies

1 other study(ies) available for mk 0852 and lamifiban

Article	Year
[Superaspirin in the platelet aggregation inhibitor therapy]. Recenti progressi in medicina, 1997, Volume: 88, Issue:12 Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Integrins; Myocardial Infarction; Oligopeptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Recurrence; Sulfoxides; Thiazolidines; Time Factors; Tyrosine	1997

Article

Year

[Superaspirin in the platelet aggregation inhibitor therapy].

Recenti progressi in medicina, 1997, Volume: 88, Issue:12

Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Integrins; Myocardial Infarction; Oligopeptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Recurrence; Sulfoxides; Thiazolidines; Time Factors; Tyrosine

1997